IP 253 (Ranitidine 150 mg)
Pill imprint IP 253 has been identified as Ranitidine hydrochloride 150 mg.
Ranitidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; gastric ulcer maintenance treatment; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for IP 253 (Ranitidine 150 mg)
- 150 mg
- 9.00 mm
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Amneal Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|66267-0188||Nucare Pharmaceuticals Inc (repackager)|
|68071-1321||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.